Genenta Science SpA Overview
Valuation check: GNTA's ROE is -70.61%, below the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow-70.61%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GNTA is -70.61%. That is below the sector sector average of 11.64%. Investors often review this figure alongside Genenta Science SpA's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, GNTA currently prints -70.61% for ROE, while the sector average sits near 11.64%. That is roughly 706.8% below the sector mean. Large gaps often invite a closer look at Genenta Science SpA's growth, margins, and balance sheet.
Return on Equity shows how effectively Genenta Science SpA converts resources into returns. At -70.61%, GNTA may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GNTA's ROE (-70.61%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
